AstraZeneca
Manufacturing · New Zealand · 11-50 Employees
View Company Info for Free
Overview
Headquarters
347-351 Parnell Parnell Rd L 2, Auckland...Phone Number
+64 93065650Website
www.symbicort.co.nzRevenue
<$5 MillionIndustry
About AstraZeneca
Is AstraZeneca your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
AstraZeneca, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if AstraZeneca had a recent Job posting/layoffs
Check out if AstraZeneca is spiking on competitors!
Check if AstraZeneca has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at AstraZeneca
Funding: Get notified immidiatlly once AstraZeneca has new funding data
Product Launch: Get notified when AstraZeneca launches new products
Earning: See what the market has to say on AstraZeneca recently announced quarterly report
Website visits: Recent activity has been detected on your website
Recommended Actions
Find VP level buyers at AstraZeneca
Find 3 more new buyers
Company Profile Activity
Activity Insights
AstraZeneca is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
AstraZeneca is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about AstraZeneca.
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding AstraZeneca
AstraZeneca offers Symbicort, a prescription medicine designed for the treatment of asthma and COPD, providing both relief and prevention of symptoms in a single inhaler. The product is suitable for all levels of asthma, delivering fast relief within 1-3 minutes while addressing airway inflammation. Targeted towards individuals suffering from asthm... Read More